Why is Snoop Dogg investing in the UK's medical cannabis? | LBC

Surrounded by barbed wire and countless cameras, the Glass Pharms facility is one of the UK’s biggest cannabis farms, licensed by the Home Office to grow for medicinal use.

The health service is limited in which approved products doctors can hand out.

But the gap is being filled somewhat by the private sector, where there is more freedom to prescribe unlicensed medicines - although these are considered to come with a higher risk.

The British pharmaceutical company partnered with Glass Pharms - Mamedica - last month announced a deal with American rapper Snoop Dogg’s investment firm, worth £4.5 million, to help them expand in the UK.

Questions have been raised, though, over whether the endorsement will help to improve the availability of medical cannabis, or if it risks glorifying the drug’s use, and sending progress into reverse.

LBC was shown around Glass Pharms, where our phones were confiscated and all outdoor clothing had to be removed and replaced with overalls, akin to hospital scrubs.

The British pharmaceutical company partnered with Glass Pharms - Mamedica - last month announced a deal with American rapper Snoop Dogg’s investment firm, worth £4.5 million, to help them expand in the UK.

Listen to the full show on the allnew LBC App

#fraserknight #cannabis #snoopdogg #nhs #health #LBC

LBC is the home of live debate around news and current affairs in the UK.

Join in the conversation and listen at

Sign up to LBC’s weekly newsletter here